8-K 1 f93731e8vk.htm FORM 8-K Dionex Corporation, Form 8-K, 10/20/2003
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

OCTOBER 20, 2003

Date of Report (Date of earliest event reported)

DIONEX CORPORATION

(Exact name of registrant as specified in its charter)
         
Delaware   000-11250   94-2647429

 
 
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (IRS Employer
Identification Number)

1228 Titan Way,
Sunnyvale, CA 94088


(Address of principal executive offices, including zip code)

(408) 737-0700


(Registrant’s telephone number, including area code)


 


Item 12. Results of Operations and Financial Condition.
SIGNATURE
INDEX TO EXHIBITS
EXHIBIT 99.1


Table of Contents

Item 12. Results of Operations and Financial Condition.

     On October 20, 2003, Dionex issued a press release announcing the financial results for the quarter ended September 30, 2003. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

     This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

         
    DIONEX CORPORATION
         
Dated: October 20, 2003   By:   /s/ Craig A. McCollam
     
        Craig A. McCollam
        Vice President, Finance and Administration and Chief Financial Officer

 


Table of Contents

INDEX TO EXHIBITS

     
Exhibit Number   Description

 
99.1   Press Release of Dionex Corporation dated October 20, 2003.